0 CHECKOUT

PRODUCT FILTERS

REGION

1,006
90
64
61
53

COUNTRY

58
13
11
8
6

CATEGORIES

  • 73
  • 124
  • 60
  • 54
  • 35
  • 33
  • 10
  • 10
  • 11
  • 14

PRICE

544
798
1,662
2,766

PUBLISHED

59
237
601
2,766

PRODUCT TYPE

2,663
83
7
6
2
2
2
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

2,766 Products

OpportunityAnalyzer: Bladder Cancer - Opportunity Analysis and Forecasts to 2017

Bladder cancer is a urologic malignancy arising from the epithelial lining of the urinary bladder Although it is the ninth most common cancer worldwide in men and women, with the highest recurrence...

Published:  December 2013
Price:  From

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2013

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2013', provides...

Published:  December 2013
Price:  From

Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H2, 2013

Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H2, 2013" provides data on the...

Published:  December 2013
Price:  From

Ependymoma Global Clinical Trials Review, H2, 2013

“Ependymoma Global Clinical Trials Review, H2, 2013" provides data on the Ependymoma clinical trial scenario This report provides elemental information and data relating to the clinical trials on Ependymoma...

Published:  December 2013
Price:  From

Metastatic Liver Cancer Global Clinical Trials Review, H2, 2013

Metastatic Liver Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Metastatic Liver Cancer Global Clinical Trials Review, H2, 2013" provides data on the Metastatic...

Published:  December 2013
Price:  From

Follicular Lymphoma Global Clinical Trials Review, H2, 2013

Follicular Lymphoma Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Follicular Lymphoma Global Clinical Trials Review, H2, 2013" provides data on the Follicular Lymphoma...

Published:  December 2013
Price:  From

Medulloblastoma Global Clinical Trials Review, H2, 2013

Medulloblastoma Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Medulloblastoma Global Clinical Trials Review, H2, 2013" provides data on the Medulloblastoma clinical trial...

Published:  December 2013
Price:  From

Gliosarcoma Global Clinical Trials Review, H2, 2013

“Gliosarcoma Global Clinical Trials Review, H2, 2013" provides data on the Gliosarcoma clinical trial scenario This report provides elemental information and data relating to the clinical trials on...

Published:  December 2013
Price:  From

Mantle Cell Lymphoma Global Clinical Trials Review, H2, 2013

“Mantle Cell Lymphoma Global Clinical Trials Review, H2, 2013" provides data on the Mantle Cell Lymphoma clinical trial scenario This report provides elemental information and data relating to the clinical...

Published:  December 2013
Price:  From

Cell Press Reviews: Cancer Therapeutics. Cell Press Reviews Series

Cell Press Reviews: Cancer Therapeutics informs, inspires, and connects cancer researchers at all stages in their careers with timely, comprehensive reviews written by leaders in the field and curated...

Published:  December 2013
Price: 

Monoclonal Antibodies Market in Colorectal Cancer to 2019 - Favorable Pricing Policy in the US and Rising Prevalence in Europe and Japan Ensures Market Growth

There are currently three monoclonal Antibody (mAb) treatments approved for metastatic colorectal cancer with the purpose of extending the patient’s lifespan; Avastin, Erbitux and Vectibix The current...

Published:  December 2013
Price:  From

Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth

Gastric and esophageal cancers are two orphan cancers of the gastrointestinal tract They are often diagnosed at advanced, incurable stages due to a late onset of symptoms, but are also associated with...

Published:  December 2013
Price:  From

Cancer Drug Design and Discovery. Edition No. 2

Cancer Drug Design and Discovery, Second Edition is an important reference on the underlying principles for the design and subsequent development of new anticancer small molecule agents. New chapters...

Published:  December 2013
Price: 

2014 World Tumor Markers Testing Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country. The report also presents strategic analyses of leading...

Published:  December 2013
Price:  From

Physician Views: Bayer's M&A Catalyst – is Xofigo a Paradigm Shifter for the Prostate Cancer Market?

Already positioned as one of the most commercially promising new drug approvals of 2013, Algeta and Bayer's prostate cancer treatment Xofigo is now driving what appears to be the inevitable acquisition...

Published:  December 2013
Price:  From

Uterine Cancer Global Clinical Trials Review, H2, 2013

Uterine Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Uterine Cancer Global Clinical Trials Review, H2, 2013" provides data on the Uterine Cancer clinical trial...

Published:  November 2013
Price:  From

Esophageal Cancer Global Clinical Trials Review, H2, 2013

Esophageal Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Esophageal Cancer Global Clinical Trials Review, H2, 2013" provides data on the Esophageal Cancer clinical...

Published:  November 2013
Price:  From

Gastric Cancer Global Clinical Trials Review, H2, 2013

Gastric Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Gastric Cancer Global Clinical Trials Review, H2, 2013" provides data on the Gastric Cancer clinical trial...

Published:  November 2013
Price:  From

Anal Cancer Global Clinical Trials Review, H2, 2013

Anal Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Anal Cancer Global Clinical Trials Review, H2, 2013" provides data on the Anal Cancer clinical trial scenario....

Published:  November 2013
Price:  From

Ovarian Cancer Global Clinical Trials Review, H2, 2013

Ovarian Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H2, 2013" provides data on the Ovarian Cancer clinical trial...

Published:  November 2013
Price:  From
Loading Indicator

Our Clients